Chau Quang Khuong

Chau Quang Khuong discloses dealings in Fusion Pharmaceuticals Inc. to SEC (Form 4). In total, 2 filings cover trades dated from 25 June 2020 to 11 November 2022.

Purchases make up the whole of the open-market record (1 purchase, €74k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2022 alone, the filings show 1 purchase and no sales.

The record was last updated on 14 November 2022 with an open-market purchase (€74k) in Fusion Pharmaceuticals Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.